These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 34348115)

  • 1. Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis.
    Jiang Z; Zhao M; Voilquin L; Jung Y; Aikio MA; Sahai T; Dou FY; Roche AM; Carcamo-Orive I; Knowles JW; Wabitsch M; Appel EA; Maikawa CL; Camporez JP; Shulman GI; Tsai L; Rosen ED; Gardner CD; Spiegelman BM; Svensson KJ
    Cell Metab; 2021 Sep; 33(9):1836-1852.e11. PubMed ID: 34348115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoproteomic mapping reveals distinct signaling actions and activation of muscle protein synthesis by Isthmin-1.
    Zhao M; Banhos Danneskiold-Samsøe N; Ulicna L; Nguyen Q; Voilquin L; Lee DE; White JP; Jiang Z; Cuthbert N; Paramasivam S; Bielczyk-Maczynska E; Van Rechem C; Svensson KJ
    Elife; 2022 Sep; 11():. PubMed ID: 36169399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus.
    Lei X; Chen H; Xu Y; Yang Z; Zhang L; Wang C; Du H
    BMJ Open Diabetes Res Care; 2024 Sep; 12(5):. PubMed ID: 39322582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
    Santos IB; de Bem GF; Cordeiro VSC; da Costa CA; de Carvalho LCRM; da Rocha APM; da Costa GF; Ognibene DT; de Moura RS; Resende AC
    Nutr Res; 2017 Jul; 43():69-81. PubMed ID: 28739056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice.
    Ren M; Pan J; Yu X; Chang K; Yuan X; Zhang C
    J Transl Med; 2022 Oct; 20(1):449. PubMed ID: 36195912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models.
    Hu W; Li M; Sun W; Li Q; Xi H; Qiu Y; Wang R; Ding Q; Wang Z; Yu Y; Lei H; Mao Y; Zhu YZ
    Pharmacol Res; 2022 Mar; 177():105917. PubMed ID: 34597809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A4 Restricts Diet-Induced Hepatic Steatosis via SREBF1-Mediated Lipogenesis and Enhances IRS-PI3K-Akt Signaling.
    Cheng C; Liu XH; He J; Gao J; Zhou JT; Fan JN; Jin X; Zhang J; Chang L; Xiong Z; Yu J; Li S; Li X
    Mol Nutr Food Res; 2022 Sep; 66(18):e2101034. PubMed ID: 35909347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. d- chiro-Inositol Ameliorates High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance via PKCε-PI3K/AKT Pathway.
    Cheng F; Han L; Xiao Y; Pan C; Li Y; Ge X; Zhang Y; Yan S; Wang M
    J Agric Food Chem; 2019 May; 67(21):5957-5967. PubMed ID: 31066268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
    Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
    J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity.
    Lopez-Pastor AR; Gomez-Hernandez A; Diaz-Castroverde S; Gonzalez-Aseguinolaza G; Gonzalez-Rodriguez A; Garcia G; Fernandez S; Escribano O; Benito M
    Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30642871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
    Kuang JR; Zhang ZH; Leng WL; Lei XT; Liang ZW
    Mol Cell Endocrinol; 2017 May; 447():106-115. PubMed ID: 28237722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
    Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
    Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models.
    Kim MK; Chae YN; Ahn GJ; Shin CY; Choi SH; Yang EK; Sohn YS; Son MH
    Arch Pharm Res; 2017 Feb; 40(2):268-281. PubMed ID: 27885461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.